Cambridge, MA, United States of America

Chester Chamberlain

This inventor holds 3 USPTO granted patents. Top assignee: Scripps Research Institute. Active years: 2007-2010.


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Chester Chamberlain: Innovator in Biosensor Technology

Introduction

Chester Chamberlain is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biosensor technology, holding a total of 3 patents. His work focuses on the development of innovative peptide synthons and biosensors that enhance our understanding of biomolecular interactions.

Latest Patents

Chamberlain's latest patents include advancements in labeled peptides, proteins, and antibodies, along with processes and intermediates useful for their preparation. His inventions provide peptide synthons that have protected functional groups for the attachment of desired moieties, such as functional molecules or probes. Additionally, he has developed peptide conjugates prepared from these synthons, along with methods for identifying optimum probe attachment sites. His biosensors utilize environmentally sensitive dyes that can locate specific biomolecules within living cells and detect chemical and physiological changes as the cells move, metabolize, and react to their environment. Notably, his methods for detecting GTP activation of a Rho GTPase protein using polypeptide biosensors represent a significant advancement in the field. When the biosensor binds to the GTP-activated Rho GTPase protein, the environmentally sensitive dye emits a signal that varies in lifetime, intensity, or wavelength compared to when it is not bound. Furthermore, he has introduced new fluorophores that respond to environmental changes, improving detection and attachment properties for use in living cells or in vitro.

Career Highlights

Chester Chamberlain is affiliated with The Scripps Research Institute, where he continues to push the boundaries of biosensor technology. His work has garnered attention for its potential applications in various fields, including medical diagnostics and cellular biology.

Collaborations

Chamberlain has collaborated with notable colleagues such as Rajeev Muthyala and Vadim Kraynov, contributing to the advancement of research in biosensor technology.

Conclusion

Chester Chamberlain's innovative work in biosensor technology and peptide synthesis has positioned him as a key figure in the field. His patents reflect a commitment to enhancing our understanding of biomolecular interactions and their implications in living systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…